GenVec's (GNVC) TNFerade Receives FDA Fast Track Designation for Treatment of Pancreatic Cancer
Tweet Send to a Friend
GenVec (Nasdaq: GNVC) announced that TNFerade(TM) has been granted Fast Track product designation by the U.S. Food and Drug Administration ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
